PhorMed on StartEngine | Deal Review

Apr 27, 2021 2 min read
PhorMed on StartEngine | Deal Review

Company's Overview

Problem Addressed: Many common life-threatening diseases require dangerous treatments that have long-lasting side-effects or few options. For example, patients suffering from Acute Myeloid Leukemia (AML), Hodgkin’s Lymphoma (HL), Parkinson’s disease (PD), and COVID-19 are faced with either the reality of no realistic treatment options or for some diseases like cancer, potentially harmful and painful treatments with long-lasting side-effects.

The Product: A proprietary drug that will potentially be able to treat patients diagnosed with AML, HL, PD, COVID-19 and other projected diseases. The company's technology, RP-323 works to “repair” the damaged cellular processes at the molecular level.

Utilizing gene therapy to target cancer and mutated cells

PhorMed Campaign's Highlights

  • Current first-line treatment options have severe side-effects and can be toxic; our technology targets the disease not just the symptoms.
  • Exciting technology with the potential to treat multiple diseases means expanding opportunities for new markets and the potential for growth.
  • The potential market is $8B+ per year.

Terms Sheet

  • Company: Phormed Inc
  • Corporate Address: 1999 Avenue Of The Stars, Suite 1100, Century City, CA 90067
  • Offering Minimum: $10,000.00
  • Offering Maximum: $5,000,000.00
  • Minimum Investment Amount (per investor): $250.00

  • Offering Type: Equity
  • Security Name: Common Stock
  • Minimum Number of Shares Offered: 10,000
  • Maximum Number of Shares Offered: 5,000,000
  • Price per Share: $1.00
  • Pre-Money Valuation: $39,000,000.00

Did I Invest In PhorMed?

I’m still in the process of writing a full deal report and decide whether or not I will invest in PhorMed. At Angel Notes, I review 100+ startups on 10+ platforms every month and send a detailed report every Saturday to subscribers of the Angel Notes newsletter (you can join through the form below). See you soon!

Table of Contents
Great! Next, complete checkout for full access to Angel Notes.
Welcome back! You've successfully signed in.
You've successfully subscribed to Angel Notes.
Success! Your account is fully activated, you now have access to all content.
Success! Your billing info has been updated.
Your billing was not updated.